Indies Pharma Jamaica Limited (JMSE:INDIES)

Jamaica · Delayed Price · Currency is JMD

2.640

+0.040 (1.54%)

At close: Sep 7, 2026

Market Cap	3.46B -18.2%
Revenue (ttm)	1.10B -7.5%
Net Income	127.86M -43.8%
EPS	0.10 -43.6%
Shares Out	1.33B
PE Ratio	27.11
Forward PE	n/a
Dividend	0.14 (5.09%)
Ex-Dividend Date	Apr 9, 2026

Volume	11,377
Open	n/a
Previous Close	2.600
Day's Range	2.600 - 2.640
52-Week Range	2.330 - 3.150
Beta	0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 8, 2026

About Indies Pharma Jamaica

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. It also distributes and sells beverages brand, dental products, and herbal supplements; cardiovascular, anti-hypertensive, circulation and anti-thrombotic, anti-cholesterol, gastro-intestinal, anti-diabetes, dermatology, antifungal, dermatology and anti-acne, NSAIDS and antipyretic, neurological, anti-psychiatry, oncological, anesthesiology, and nephrology agents; and venous circulation and hemorrhoids, antibiotics oral, ant... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 2003

Employees 64

Stock Exchange Jamaica Stock Exchange

Ticker Symbol INDIES

Full Company Profile

Financial Performance

In fiscal year 2025, Indies Pharma Jamaica's revenue was 1.13 billion, a decrease of -2.82% compared to the previous year's 1.16 billion. Earnings were 181.29 million, a decrease of -18.04%.

Financial Statements